Search Result "human MAO"


Research Article

Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold

Journal: Current Neuropharmacology
Volume: 15 Issue: 8 Year: 2017 Page: 1117-1135
Author(s): Maykel Cruz-Monteagudo,Fernanda Borges,M.Natalia D. S. Cordeiro,Aliuska Morales Helguera,Eduardo Tejera,Cesar Paz-y-Mino,Aminael Sanchez-Rodriguez,Yunier Perera-Sardina,Yunierkis Perez-Castillo

Hansch Analysis of Novel Acetamide Derivatives as Highly Potent and Specific MAO-A Inhibitors

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2016 Page: 143-151
Author(s): Ashish Pathak,Pradeep K. Singour,Amit K. Srivastava,Panchanan Gouda,Sunil Kumar,Bhupendra K. Goutam

MAO Inhibitory Activity of 4, 5-Dihydro-1 HPyrazole Derivatives: A Platform To Design Novel Antidepressants

Ebook: Frontiers in Drug Design and Discovery

Volume: 10 Year: 2021
Author(s): Vishnu Nayak Badavath,Venkatesan Jayaprakash
Doi: 10.2174/97898114215631211001

Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson’s Disease

Journal: Current Genomics
Volume: 14 Issue: 8 Year: 2013 Page: 518-533
Author(s): Jolanta Dorszewska,Michal Prendecki,Anna Oczkowska,Agata Rozycka,Margarita Lianeri,Wojciech Kozubski

In Silico Approaches to Naturally Existing Chalcones and Flavonoids on Mao Inhibitory Action: A Boon to CNS Drug Discovery

Ebook: Flavonoids and Phenolics

Volume: 1 Year: 2022
Author(s): Della Grace Thomas Parambi,Mutairah Shaker Alshammari,Mohammed A. Abdelgawad,Dibya Sundar Panda,Manoj Kumar Sachidanandan,Leena K. Pappachen
Doi: 10.2174/9789815079098122010009

Parkinson's Disease Management. Part II- Discovery of MAO-B Inhibitors Based on Nitrogen Heterocycles and Analogues

Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 20 Year: 2012 Page: 2116-2130
Author(s): Joana Reis,Igor Encarnacao,Alexandra Gaspar,Aliuska Morales,Nuno Milhazes,Fernanda Borges

Research Article

Fighting Against Alzheimer's Disease: Synthesis of New Pyrazoline and Benzothiazole Derivatives as New Acetylcholinesterase and MAO Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 15 Issue: 4 Year: 2018 Page: 414-427
Author(s): Gulhan Turan-Zitouni,Weiam Hussein,Begum Nurpelin Saglik,Merve Baysal,Zafer Asim Kaplancikli

Leflunomide, a Reversible Monoamine Oxidase Inhibitor

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2016 Page: 112-119
Author(s): Jacobus P. Petzer,Anél Petzer

Selegiline (l-Deprenyl) as a Unique Neuroprotective Agent for Chronic Neurodegenerative Disorders- A Lesson from MAO Inhibition

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4 Issue: 4 Year: 2004 Page: 255-267
Author(s): Ruey-Meei Wu, Dennis L. Murphy, Chuang C. Chiueh

Research Article

Design, Synthesis and Evaluation of 8-Thiosubstituted 1,3,7- Trimethylxanthine Hydrazones with In Vitro Neuroprotective and MAO-B Inhibitory Activities

Journal: Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2020 Page: 326-339
Author(s): Javor Mitkov,Alexandra Kasabova-Angelova,Magdalena Kondeva-Burdina,Virginia Tzankova,Diana Tzankova,Maya Georgieva,Alexander Zlatkova

Previous   Next

Go To   Results 11 - 20 of 4871

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy